The looming tide of nontuberculous mycobacterial infections in Portugal and Brazil [PDF]
, 2016 Nontuberculous mycobacteria (NTM) are widely disseminated in the environment and an emerging cause of infectious diseases worldwide. Their remarkable natural resistance to disinfectants and antibiotics and an ability to survive under low-nutrient ...
Alarico, Susana +4 more
core +1 more source
Frontiers in Microbiology, 2018 Accurate and timely mycobacterial species identification is imperative for successful diagnosis, treatment, and management of disease caused by nontuberculous mycobacteria (NTM).
L. Elaine Epperson +11 more
doaj +1 more source
Status and potential of bacterial genomics for public health practice : a scoping review [PDF]
, 2019 Background: Next-generation sequencing (NGS) is increasingly being translated into routine public health practice, affecting the surveillance and control of many pathogens.
Boon, Nele AM +6 more
core +2 more sources
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis [PDF]
, 2015 Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause chronic pulmonary infection, particularly in individuals with preexisting inflammatory lung disease such as cystic fibrosis(CF).
Bilton, Diana +19 more
core +11 more sources
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020 [PDF]
, 2023 Introduction. Nontuberculous mycobacteria (NTM) are environmental mycobacteria which may cause pulmonary and extrapulmonary diseases. These organisms are difficult to treat due to their intrinsic drug-resistance.
Fattorini, Lanfranco +4 more
core +5 more sources
Rapid and Accurate Identification of Nontuberculous Mycobacteria Directly from Positive Primary MGIT Cultures by MALDI-TOF MS [PDF]
, 2022 Over the last years, nontuberculous mycobacteria (NTM) have emerged as important human pathogens. Accurate and rapid mycobacterial species identification is needed to successfully diagnose, treat, and manage infections caused by NTM.
Fais R. +4 more
core +1 more source
Accurate subspecies-level identification of clinically significant Mycobacterium avium and Mycobacterium intracellulare by whole-genome sequencing [PDF]
, 2023 Whole genome sequencing (WGS) of Mycobacterium avium complex (MAC) isolates in the clinical laboratory setting allows for rapid and reliable subspecies identification of a closely related complex of human pathogens. We developed a bioinformatics pipeline
Chawla, Rachit +6 more
core +1 more source
Emerging Infectious Diseases, 2017 Mycobacterium chimaera was present at high rates (>80%) in heater–cooler units (HCUs) from all 5 thoracic surgery departments in Denmark. Isolates were clonal to HCU-associated isolates from the United States (including some from patients) and United ...
Erik Svensson +5 more
doaj +1 more source
BMC Infectious Diseases, 2022 Background Mycobacterium (M.) chimaera is a non-tuberculous mycobacterium (NTM) that belongs to M. avium complex (MAC). In patients with cystic fibrosis (CF), MAC can cause bronchopulmonary infections that can be prolonged and difficult to treat.
Alexandra Kavvalou +7 more
doaj +1 more source
Bronchiectasis:a case-based approach to investigation and management [PDF]
, 2018 Bronchiectasis is a chronic respiratory disease characterised by a syndrome of productive cough and recurrent respiratory infections due to permanent dilatation of the bronchi.
Agarwal +17 more
core +3 more sources